Changes of histaminopexy in patients with bronchial asthma and chronic urticaria after histaglobin administration.
In patients suffering from bronchial asthma and chronic urticaria, the value of histaminopexy was determined prior and after histaglobin treatment (3 injections-1 amp. at 7 days intervals). The value of histaminopexy after histaglobin treatment rised over -240% and was well correlated with the clinical effect of the therapy. These observations are considered as an "ex iuvantibus" evidence that histaminopexy may play a role in the etiopathogenesis of allergic disorders.
D000328:Adult; D000368:Aged; D001249:Asthma / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D001798:Blood Proteins / Q000378:metabolism; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006632:Histamine / Q000627:therapeutic use*; D006633:Histamine Antagonists / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D014581:Urticaria / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D005719:gamma-Globulins / Q000627:therapeutic use*
D001798:Blood Proteins; D004338:Drug Combinations; D006633:Histamine Antagonists; D005719:gamma-Globulins; C002114:Histaglobin; D006632:Histamine